Home / Generic Drugs / Oligodendroglioma Global Clinical Trials Review, Q4, 2010

Oligodendroglioma Global Clinical Trials Review, Q4, 2010

Published: Dec 2010 | No Of Pages: 51 | Published By: GlobalData

Product Synopsis

GlobalData's clinical trial report, “Oligodendroglioma Global Clinical Trials Review, Q4, 2010"" provides data on the Oligodendroglioma clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Oligodendroglioma. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Oligodendroglioma).

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
  • Overview of the enrollment pattern by phase for the past decade
  • Number of clinical trials segmented by key drugs
  • Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
  • Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others

Reasons to buy

  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Oligodendroglioma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by BRIC Nations 13
Clinical Trials by Phase 14
In Progress Trials by Phase 15
Clinical Trials by Trial Status 16
Unaccomplished Trials of Oligodendroglioma 17
Subjects Recruited Over a Period of Time 19
Prominent Sponsors 20
Top Companies Participating in Oligodendroglioma Therapeutics Clinical Trials 22
Prominent Drug Comparison 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
TransMolecular, Inc. 24
Clinical Trial Overview of TransMolecular, Inc. 24
Neopharm Ltd. 25
Clinical Trial Overview of Neopharm Ltd. 25
Pharmacyclics, Inc. 26
Clinical Trial Overview of Pharmacyclics, Inc. 26
Clinical Trial Overview of Top Universities / Institutes / Hospitals 27
National Cancer Institute (NCI) 27
Clinical Trial Overview of National Cancer Institute (NCI) 27
Wake Forest University 28
Clinical Trial Overview of Wake Forest University 28
City of Hope National Medical Center 29
Clinical Trial Overview of City of Hope National Medical Center 29
Marmara University 30
Clinical Trial Overview of Marmara University 30
Neuro-Oncology Working Group of the German Cancer Society 31
Clinical Trial Overview of Neuro-Oncology Working Group of the German Cancer Society 31
Les Hopitaux Universitaires de Strasbourg 32
Clinical Trial Overview of Les Hopitaux Universitaires de Strasbourg 32
Abramson Cancer Center 33
Clinical Trial Overview of Abramson Cancer Center 33
Mayo Clinic 34
Clinical Trial Overview of Mayo Clinic 34
Ludwig-Maximilians-Universitat Munich 35
Clinical Trial Overview of Ludwig-Maximilians-Universitat Munich 35
Duke University 36
Clinical Trial Overview of Duke University 36
University of California, San Francisco 37
Clinical Trial Overview of University of California, San Francisco 37
University of Pittsburgh 38
Clinical Trial Overview of University of Pittsburgh 38
Columbia University 39
Clinical Trial Overview of Columbia University 39
Sun Yat-sen University 40
Clinical Trial Overview of Sun Yat-sen University 40
National Taiwan University Hospital 41
Clinical Trial Overview of National Taiwan University Hospital 41
Case Comprehensive Cancer Center 42
Clinical Trial Overview of Case Comprehensive Cancer Center 42
Dana-Farber Cancer Institute 43
Clinical Trial Overview of Dana-Farber Cancer Institute 43
Roswell Park Cancer Institute 44
Clinical Trial Overview of Roswell Park Cancer Institute 44
Weill Cornell Medical College 45
Clinical Trial Overview of Weill Cornell Medical College 45
Emory University 46
Clinical Trial Overview of Emory University 46
Hopitaux Universitaires de Geneve 47
Clinical Trial Overview of Hopitaux Universitaires de Geneve 47

Appendix 48
Abbreviations 48
Definitions 48
Research Methodology 49
Secondary Research 49
About GlobalData 50
Contact Us 50
Disclaimer 50
Source 51

Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Zone, 2010* 7
Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Top Countries, 2010* 8
Oligodendroglioma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2010* 9
Oligodendroglioma Therapeutics Clinical Trials, Asia-Pacific ,Top Countries, 2010* 10
Oligodendroglioma Therapeutics Clinical Trials, Europe, Top Five Countries, 2010* 11
Oligodendroglioma Therapeutics Clinical Trials, North America, Top Countries, 2010* 12
Oligodendroglioma Therapeutics Clinical Trials, BRIC Countries, 2010* 13
Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Phase, 2010* 14
Oligodendroglioma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2010* 15
Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 16
Oligodendroglioma Therapeutics Market, Global, Withdrawn Clinical Trials, 2010* 17
Oligodendroglioma Therapeutics Market, Global, Terminated Clinical Trials, 2010* 18
Oligodendroglioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 19
Oligodendroglioma Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 21
Oligodendroglioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010* 22
Oligodendroglioma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2010** 23
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by TransMolecular, Inc., 2010* 24
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Neopharm Ltd., 2010* 25
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pharmacyclics, Inc., 2010* 26
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute (NCI), 2010* 27
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2010* 28
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2010* 29
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Marmara University, 2010* 30
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Neuro-Oncology Working Group of the German Cancer Society, 2010* 31
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Les Hopitaux Universitaires de Strasbourg, 2010* 32
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2010* 33
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2010* 34
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ludwig-Maximilians-Universitat Munich, 2010* 35
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2010* 36
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2010* 37
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2010* 38
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2010* 39
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2010* 40
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2010* 41
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2010* 42
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2010* 43
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2010* 44
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2010* 45
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2010* 46
Oligodendroglioma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2010* 47

Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Top Countries, 2010* 8
Oligodendroglioma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2010* 9
Oligodendroglioma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2010* 10
Oligodendroglioma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2010* 11
Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Phase (%), 2010* 14
Oligodendroglioma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2010* 15
Oligodendroglioma Therapeutics Market, Global, Clinical Trials by Trial Status, 2010* 16
Oligodendroglioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 19
Oligodendroglioma Therapeutics Clinical Trials, Global, Key Sponsors, 2010* 20
Oligodendroglioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2010* 22
Oligodendroglioma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2010* 23
GlobalData Methodology 49

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +